These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25424140)

  • 21. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmogenic right ventricular cardiomyopathy: ECG progression over time and correlation with long-term follow-up.
    Gallo C; Blandino A; Giustetto C; Anselmino M; Castagno D; Richiardi E; Gaita F
    J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):418-24. PubMed ID: 27119598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of arrhythmogenic right ventricular cardiomyopathy.
    Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
    Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Canpolat U; Kabakçi G; Aytemir K; Dural M; Sahiner L; Yorgun H; Sunman H; Bariş Kaya E; Tokgözoğlu L; Oto A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1260-6. PubMed ID: 23845044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
    Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Bosman LP; Te Riele ASJM
    Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Peters S; Truemmel M; Koehler B
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Calkins H
    Curr Cardiol Rep; 2016 Jun; 18(6):53. PubMed ID: 27108363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmogenic Right Ventricular Cardiomyopathy.
    Krahn AD; Wilde AAM; Calkins H; La Gerche A; Cadrin-Tourigny J; Roberts JD; Han HC
    JACC Clin Electrophysiol; 2022 Apr; 8(4):533-553. PubMed ID: 35450611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
    Dohadwala M; Link MS
    Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arrhythmogenic right ventricular cardiomyopathy (dysplasia): etiology, clinical presentation, diagnosis and treatment].
    Czarnowska E; Włodarska EK; Zaleska T
    Kardiol Pol; 2003 Jan; 58(1):58-63. PubMed ID: 14502306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) - What We Have Learned after 40 Years of the Diagnosis of This Clinical Entity.
    Elias Neto J; Tonet J; Frank R; Fontaine G
    Arq Bras Cardiol; 2019 Jan; 112(1):91-103. PubMed ID: 30673021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
    Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.